How much funding has Celularity raised?

Celularity has raised $645.0M in total funding, most recently a Series A round.

When was Celularity founded?

Celularity was founded in 2016.

Where is Celularity headquartered?

Celularity is headquartered in Florham Park, New Jersey, United States.

What industry is Celularity in?

Celularity operates in Biotech, Healthcare.

How many employees does Celularity have?

Celularity has 51-200 employees.

Celularity

The Next Evolution in Cellular Medicine

Florham Park, United States · Founded 2016 · $645.0M raised

Biotech

Healthcare

Headquarters: Florham Park, New Jersey
Employees: 51–200
Founded: 2016
Business Model: B2B

Website: celularity.com
Total Funding: $645.0M
Last Round: $45.0M Series AJan 2021
Rounds: 3

About

Celularity, headquartered in Florham Park, New Jersey, is a clinical and commercial stage biotechnology company leading the next evolution in cellular and regenerative medicine. The company's innovative approach harnesses the unique therapeutic potential locked within the postpartum placenta — nature's immunotherapy engine — to develop off-the-shelf allogeneic placenta-derived cellular therapies including mesenchymal-like adherent stromal cells (MLASCs), Natural Killer (NK) cells, and engineered T cells including CAR-T cells. Celularity targets serious unmet medical needs across age-related diseases, cancer, infectious diseases, and degenerative conditions. Celularity has more than 15 active and completed clinical trials and operates an approximately 150,000-square-foot cGMP-ready manufacturing facility in Florham Park, NJ.

Summary

Celularity is a Biotech company based in Florham Park, United States, founded in 2016. It has raised $645.0M in total across 3 rounds, most recently a $45.0M Series A round in Jan 2021.

LinkedIn X (Twitter)